COG — Cambridge Cognition Holdings Share News
0.000.00%
- £17.02m
- £16.76m
- £9.40m
REG - Cambridge Cognition - Changes to Board and Management
AnnouncementREG - Cambridge Cognition - Interim Results
AnnouncementRCS - Cambridge Cognition - Monument Therapeutics Partnership with FNIH
AnnouncementREG - Cambridge Cognition - Launch of Speaker Identification Solution
AnnouncementREG - Cambridge Cognition - Trading update for period ended 30 June 2025
AnnouncementREG - Cambridge Cognition - Result of AGM
AnnouncementRCS - Cambridge Cognition - Monument Therapeutics Success in Phase I Results
AnnouncementREG - Cambridge Cognition - Notice of AGM
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Preliminary Unaudited Results
AnnouncementREG - Cambridge Cognition - Notice of Results and Investor Presentation
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Block Listing Return
AnnouncementRCS - Cambridge Cognition - CANTAB® used for major global brain health study
AnnouncementRCS - Cambridge Cognition - Cambridge Cognition submits FDA Letter of Intent
AnnouncementREG - Cambridge Cognition - Board Appointment
AnnouncementREG - Cambridge Cognition - Launch of in-house rater training service
Announcement